Linked research, clinical, and regulatory source pathways.
Company profile
About Veradigm
Veradigm is a healthcare technology company that operates a comprehensive network connecting multiple healthcare stakeholders including life sciences companies, health plans and payers, healthcare providers, and health IT vendors. The company provides an integrated suite of solutions spanning electronic health records (EHR), practice management, revenue cycle services, and patient engagement platforms for healthcare providers. For life sciences organizations, Veradigm offers NLP-enriched real-world data solutions, real-world evidence research services, and point-of-care marketing capabilities. The company serves health plans and payers with gap closure services, risk adjustment analytics, quality management tools, data exchange and coding solutions, and clearinghouse EDI services. Veradigm's platform includes AI-powered patient scheduling, ePrescribing capabilities for controlled substances, clinical data registries, and enterprise resource planning tools for supply chain and fiscal management. The company leverages its extensive provider network to deliver insights and analytics that support value-based care, improve clinical efficiency, and enable data-driven decision making across the healthcare ecosystem. Veradigm's solutions are designed to streamline operations, maximize revenue, and improve patient outcomes while facilitating collaboration between payers and providers.
Company description Veradigm official website
Primary marketPopulation Health & Healthcare Analytics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Veradigm?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Ambulatory Practices
- Government Programs
- Health IT Vendors
- Health Systems
- Life Sciences
- Payers
- Pharma
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: Cerner, Clearinghouse EDI systems, Epic, Lab systems, Multiple EHR vendors via DORN, Radiology centers.
Geographic context
MarketsUSA
Company sourceOfficial website
Company milestones
Platform expansion
The Veradigm Network recognized for excellence in 2025
Partnerships
Recorded partners
No partners are currently listed.
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Assessing the impact of buprenorphine for opioid use disorder on infectious disease management.Journal of substance use and addiction treatment · Oct 1, 2026
Real-World Clinical and Economic Consequences of Next-Generation Anaplastic Lymphoma Kinase-Positive (ALK +) Tyrosine Kinase Inhibitors (TKIs) in Patients with TKI-Naïve ALK + Metastatic Non-Small Cell Lung Cancer in the United States.Advances in therapy · Jul 9, 2026
Interim Effectiveness of 2025-2026 mRNA-1283 and BNT162b2 COVID-19 Vaccines Against COVID-19-Related Outcomes Among Adults Aged ≥ 65 Years in the United States.Infectious diseases and therapy · Jun 24, 2026
Incidence of COVID-19 and Influenza-Related Outcomes and Vaccinations in the United States, October 2022 Through December 2024.Vaccines · May 8, 2026
Burden of metabolic dysfunction-associated steatohepatitis, with and without metabolic syndrome, obesity, or diabetes.BMC gastroenterology · Apr 6, 2026
Economic Burden Associated with Negative Symptoms Identified Through Natural Language Processing Among Patients with Schizophrenia in the United States.Schizophrenia bulletin · Mar 7, 2026
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Gap closure improvement
Proactive, clinically-driven services to help health plans close care gaps
Revenue cycle optimization
Minimize denials, enhance coding, ensure timely payments
Quality performance enhancement
Analytics to help plans enhance Quality performance across member base
Operational efficiency
Streamline operations, reduce costs, increase efficiency through automation
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Veradigm
Recent articles published on Veradigm's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Population Health & Healthcare Analytics
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.